These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 11660533

  • 61. Regulatory orphans: juvenile prisoners as transvulnerable research subjects.
    Reed JG.
    IRB; 1999; 21(2):9-14. PubMed ID: 11657875
    [No Abstract] [Full Text] [Related]

  • 62. The politics of informed consent.
    Weston HB.
    Natl Forum; 1978; 58(4):23-6. PubMed ID: 11661867
    [No Abstract] [Full Text] [Related]

  • 63. FDA seeks public comment on informed consent rules in combat situations.
    Hastings Cent Rep; 1997; 27(5):43. PubMed ID: 11645003
    [No Abstract] [Full Text] [Related]

  • 64. Constraints on experimentation: protecting children to death.
    Holder AR.
    Yale Law Policy Rev; 1988; 6(1):137-56. PubMed ID: 11650241
    [No Abstract] [Full Text] [Related]

  • 65. IRBs and research with human biological materials.
    Maloney DM.
    Hum Res Rep; 1999 Jan; 14(1):2. PubMed ID: 11657556
    [No Abstract] [Full Text] [Related]

  • 66. Informed consent to participate in research: Part II.
    Levine RJ.
    Bioethics Dig; 1977 Apr; 1(12):1-16. PubMed ID: 11664810
    [No Abstract] [Full Text] [Related]

  • 67. Non-therapeutic medical research involving human subjects.
    Bloom MJ.
    Syracuse Law Rev; 1973 Apr; 24():1067-1099. PubMed ID: 11664224
    [No Abstract] [Full Text] [Related]

  • 68. Institutional review boards and public health research: an analysis.
    Hogue LL.
    Univ Ark Little Rock Law J; 1978 Apr; 1(2):428-54. PubMed ID: 11661619
    [No Abstract] [Full Text] [Related]

  • 69. A look at the bioresearch monitoring program: the agency perspective.
    Brisson EL.
    Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578
    [No Abstract] [Full Text] [Related]

  • 70. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B.
    IRB; 1994 Apr; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract] [Full Text] [Related]

  • 71. Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical?
    Cho MK.
    IRB; 1994 Apr; 16(1-2):12-5. PubMed ID: 11652321
    [No Abstract] [Full Text] [Related]

  • 72. Using the brain dead for medical research.
    Martyn SR.
    Utah Law Rev; 1986 Apr; 1986(1):1-28. PubMed ID: 11651917
    [No Abstract] [Full Text] [Related]

  • 73. Research involving children: an interpretation of the new regulations.
    Levine RJ.
    IRB; 1983 Apr; 5(4):1-5. PubMed ID: 11649521
    [No Abstract] [Full Text] [Related]

  • 74. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
    Maloney DM.
    Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
    [No Abstract] [Full Text] [Related]

  • 75. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
    Prentice ED, Antonson DL, Leibrock LG, Kelso TK, Sears TD.
    IRB; 1993 Jan; 15(5):1-7. PubMed ID: 11659703
    [No Abstract] [Full Text] [Related]

  • 76. Human experimentation: the review process in practice.
    Cowan DH.
    Case West Reserve Law Rev; 1975 Jan; 25(3):533-64. PubMed ID: 11661165
    [No Abstract] [Full Text] [Related]

  • 77. Power, advocacy, and informed consent forms.
    Smith ML.
    J Calif Alliance Ment Ill; 1994 Jan; 5(1):25-7. PubMed ID: 11653311
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.